申请人:Ma Jingyuan
公开号:US20100216827A1
公开(公告)日:2010-08-26
Aryl GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.
提供了芳基GPR120激动剂。这些化合物对于治疗代谢性疾病,包括II型糖尿病和与糖代谢控制不良有关的疾病非常有用。